189 related articles for article (PubMed ID: 9779863)
1. A case of Stevens-Johnson syndrome associated with oxaprozin therapy.
Bell MJ; Bishara LD
J Rheumatol; 1998 Oct; 25(10):2026-8. PubMed ID: 9779863
[TBL] [Abstract][Full Text] [Related]
2. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
[TBL] [Abstract][Full Text] [Related]
3. Case report: oxaprozin and fatal toxic epidermal necrolysis.
Paul CN; Voigt DW; Clyne KE; Hansen SL
J Burn Care Rehabil; 1998; 19(4):321-3. PubMed ID: 9710730
[TBL] [Abstract][Full Text] [Related]
4. Oxaprozin: a new NSAID.
al-Faks MA; Pugh MC
Orthop Rev; 1992 May; 21(5):558, 560-3. PubMed ID: 1603605
[TBL] [Abstract][Full Text] [Related]
5. Oxaprozin for arthritis.
Med Lett Drugs Ther; 1993 Feb; 35(890):15-6. PubMed ID: 8426570
[No Abstract] [Full Text] [Related]
6. Stevens-Johnson syndrome associated with Malarone antimalarial prophylaxis.
Emberger M; Lechner AM; Zelger B
Clin Infect Dis; 2003 Jul; 37(1):e5-7. PubMed ID: 12830430
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome associated with oral minoxidil: a case report.
Callen EC; Church CO; Hernandez CL; Thompson ED
J Nephrol; 2007; 20(1):91-3. PubMed ID: 17347980
[TBL] [Abstract][Full Text] [Related]
8. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options.
Allegra A; Alonci A; Penna G; Russo S; Gerace D; Greve B; D'Angelo A; Catena S; Musolino C
Hematol Oncol; 2012 Mar; 30(1):41-5. PubMed ID: 21702057
[TBL] [Abstract][Full Text] [Related]
10. Cycloserine-induced Stevens-Johnson syndrome in an AIDS patient with multidrug-resistant tuberculosis.
Akula SK; Aruna AS; Johnson JE; Anderson DS
Int J Tuberc Lung Dis; 1997 Apr; 1(2):187-90. PubMed ID: 9441086
[TBL] [Abstract][Full Text] [Related]
11. Positive patch test to diclofenac in Stevens-Johnson syndrome.
Alonso R; Enrique E; Cisteró A
Contact Dermatitis; 2000 Jun; 42(6):367. PubMed ID: 10871116
[No Abstract] [Full Text] [Related]
12. Stevens-Johnson syndrome: a case report.
Shetty SR; Chatra L; Shenai P; Rao PK
J Oral Sci; 2010 Jun; 52(2):343-6. PubMed ID: 20587964
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome in an HIV-infected patient.
Blitz M; Spivack E; Kerpel SM; Freedman PD
AIDS Read; 1999; 9(3):184-5, 190. PubMed ID: 12728904
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN
Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806
[TBL] [Abstract][Full Text] [Related]
15. Gastric irritation of oxaprozin, a new nonsteroidal, antiinflammatory drug, in comparison to acetylsalicylic acid and indomethacin: a gastric potential difference analysis.
Lücker PW; Venitz J; Ahrens S; Kaiser PM
Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):469-75. PubMed ID: 3683021
[TBL] [Abstract][Full Text] [Related]
16. Stevens-Johnson syndrome: pathogenesis, diagnosis, and management.
Hazin R; Ibrahimi OA; Hazin MI; Kimyai-Asadi A
Ann Med; 2008; 40(2):129-38. PubMed ID: 18293143
[TBL] [Abstract][Full Text] [Related]
17. [Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk].
Gómez-Criado MS; Ayani I; León-Colombo T; Ramos ML; Reneses MJ
Rev Neurol; 2004 Jun 1-15; 38(11):1056-60. PubMed ID: 15202085
[TBL] [Abstract][Full Text] [Related]
18. [Severe case of Stevens-Johnson syndrome in a 11-year-old boy].
Zabel J; Karaś Z
Wiad Lek; 1982 May; 35(5):357-60. PubMed ID: 6981258
[No Abstract] [Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
Sane SP; Bhatt AD
J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
[TBL] [Abstract][Full Text] [Related]
20. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
